Breaking News Instant updates and real-time market news.

ADMS

Adamas Pharmaceuticals

$35.08

-0.39 (-1.10%)

06:02
12/13/17
12/13
06:02
12/13/17
06:02

Adamas Pharmaceuticals named a best idea for 2018 at Cowen

Cowen analyst Ken Cacciatore views shares of Adamas Pharmaceuticals as "meaningfully undervalued" at current levels. He calls the stock a best idea for 2018 and keeps an Outperform rating on the name with a $55 price target. The analyst is confident that Gocovri, which is now on the market, will find a "significant place" in the Parkinson's disease treatment paradigm. He says Adamas has successfully developed an extended release amantadine for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease.

ADMS Adamas Pharmaceuticals
$35.08

-0.39 (-1.10%)

10/04/17
PIPR
10/04/17
NO CHANGE
Target $30
PIPR
Overweight
Piper Jaffray stays bullish on Adamas after physician survey
Piper Jaffray analyst David Amsellem says he's staying bullish on Adamas Pharmaceuticals following a "brief survey" of 25 movement disorder specialists. The feedback shows that while there is no consensus, a "significant group" of physicians, even ahead of the launch, view Adamas' Gocovri as a differentiated, potentially valued option for Levodopa-induced dyskinesia patients, Amsellem tells investors in a research note. He continues to believe that peak U.S. sales of at least $200M for the drug are realistic. The analyst reiterates an Overweight rating on Adamas with a $30 price target.
10/25/17
NEED
10/25/17
NO CHANGE
Target $38
NEED
Buy
Adamas FDA orphan exclusivity not a surprise, says Needham
Needham analyst Serge Belanger said it is now a surprise that the FDA granted Adamas seven-years orphan drug exclusivity to Gocovri, or ADS-5102, given that it's in accordance with the FDA's orphan drug designation which was granted to ADS-5102 back in April 2015. Gocovri was FDA approved in August and is expected to become commercially available in November 2017 ahead of a more formal launch in January 2018, the analyst wrote in a note to investors. Belanger said the seven-year exclusivity will allow Adamas to draw-down the $65M tranche from the $100M royalty-backed note. Shares are Buy rated with a $38 price target.
10/30/17
10/30/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Sotheby's (BID) initiated with a Buy at Aegis. 2. Alnylam (ALNY) initiated with a Buy at FBR Capital. 3. Adamas Pharmaceuticals (ADMS) initiated with an Outperform at Evercore ISI. 4. Vipshop (VIPS) initiated with a Neutral at UBS. 5. Rhythm Pharmaceuticals (RYTM) initiated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/29/17
NORL
11/29/17
INITIATION
Target $70
NORL
Outperform
Adamas Pharmaceuticals initiated with an Outperform at Northland
Northland analyst Carl Byrnes initiated Adamas Pharmaceuticals with an Outperform and $70 price target. The analyst said Adamas' GOCOVRI is a breakthrough in treating Parkinson's patients that have developed dyskinesia as a result of long-term exposure to levodopa therapy and sees peak sales exceeding $750M.

TODAY'S FREE FLY STORIES

GS

Goldman Sachs

$231.01

4.71 (2.08%)

09:36
07/17/18
07/17
09:36
07/17/18
09:36
Periodicals
Lloyd Blankfein writes farewell memo to Goldman Sachs team, NY Times reports »

Goldman Sachs CEO LLoyd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVRO

Nevro

$58.79

1.04 (1.80%)

09:35
07/17/18
07/17
09:35
07/17/18
09:35
Recommendations
Nevro analyst commentary  »

Nevro price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

FLT

FleetCor

$216.11

-4.06 (-1.84%)

09:35
07/17/18
07/17
09:35
07/17/18
09:35
Initiation
FleetCor initiated  »

FleetCor initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$66.95

-0.06 (-0.09%)

09:35
07/17/18
07/17
09:35
07/17/18
09:35
Initiation
Square initiated  »

Square initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 15

    Aug

  • 16

    Aug

FIS

FIS

$107.72

-0.45 (-0.42%)

09:35
07/17/18
07/17
09:35
07/17/18
09:35
Initiation
FIS initiated  »

FIS initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

09:35
07/17/18
07/17
09:35
07/17/18
09:35
General news
Treasury Action: yields traded mixed-to-lower with stocks »

Treasury Action: yields…

EPAM

Epam Systems

$132.28

-1.3 (-0.97%)

09:34
07/17/18
07/17
09:34
07/17/18
09:34
Initiation
Epam Systems initiated  »

Epam Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 15

    Aug

  • 16

    Aug

PAYX

Paychex

$69.99

-0.57 (-0.81%)

09:34
07/17/18
07/17
09:34
07/17/18
09:34
Initiation
Paychex initiated  »

Paychex initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FISV

Fiserv

09:34
07/17/18
07/17
09:34
07/17/18
09:34
Initiation
Fiserv initiated  »

Fiserv initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

CLGX

CoreLogic

$53.31

0.04 (0.08%)

09:33
07/17/18
07/17
09:33
07/17/18
09:33
Initiation
CoreLogic initiated  »

CoreLogic initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

ADS

Alliance Data

$218.91

-24.58 (-10.09%)

09:33
07/17/18
07/17
09:33
07/17/18
09:33
Initiation
Alliance Data initiated  »

Alliance Data initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 08

    Aug

WU

Western Union

$20.27

-0.09 (-0.44%)

09:33
07/17/18
07/17
09:33
07/17/18
09:33
Initiation
Western Union initiated  »

Western Union initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADP

ADP

$137.13

-0.19 (-0.14%)

09:33
07/17/18
07/17
09:33
07/17/18
09:33
Initiation
ADP initiated  »

ADP initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

DXC

DXC Technology

$85.74

-0.41 (-0.48%)

09:32
07/17/18
07/17
09:32
07/17/18
09:32
Initiation
DXC Technology initiated  »

DXC Technology initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$167.63

-0.48 (-0.29%)

09:32
07/17/18
07/17
09:32
07/17/18
09:32
Initiation
Accenture initiated  »

Accenture initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$63.96

-0.74 (-1.14%)

09:32
07/17/18
07/17
09:32
07/17/18
09:32
Technical Analysis
Technical Earnings Preview: CSX may have double-topped before news »

On the 1-year, daily…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 26

    Aug

GPN

Global Payments

$117.00

-0.98 (-0.83%)

09:32
07/17/18
07/17
09:32
07/17/18
09:32
Initiation
Global Payments initiated  »

Global Payments initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

TSS

TSYS

09:31
07/17/18
07/17
09:31
07/17/18
09:31
Initiation
TSYS initiated  »

TSYS initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

RARE

Ultragenyx

$84.32

-0.23 (-0.27%)

09:31
07/17/18
07/17
09:31
07/17/18
09:31
Recommendations
Ultragenyx analyst commentary  »

Ultragenyx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

KTOS

Kratos Defense

$12.85

0.14 (1.10%)

09:31
07/17/18
07/17
09:31
07/17/18
09:31
Hot Stocks
Kratos Defense receives $8.5M in orders in support of C5 programs »

Kratos Defense announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTSH

Cognizant

$81.97

0.26 (0.32%)

09:31
07/17/18
07/17
09:31
07/17/18
09:31
Initiation
Cognizant initiated  »

Cognizant initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 15

    Aug

  • 16

    Aug

LTC

LTC Properties

$41.84

-0.32 (-0.76%)

09:31
07/17/18
07/17
09:31
07/17/18
09:31
Hot Stocks
LTC Properties acquires two communities for $25.2M »

LTC Properties announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WP

Worldpay

$86.51

(0.00%)

09:31
07/17/18
07/17
09:31
07/17/18
09:31
Initiation
Worldpay initiated  »

Worldpay initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

FDC

First Data

$22.24

-0.06 (-0.27%)

09:31
07/17/18
07/17
09:31
07/17/18
09:31
Initiation
First Data initiated  »

First Data initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

BR

Broadridge

$117.70

-0.27 (-0.23%)

09:31
07/17/18
07/17
09:31
07/17/18
09:31
Initiation
Broadridge initiated  »

Broadridge initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.